Thursday 23 January 2020

3D Bioprinting Market Trends, Applications and Competitive Landscape By 2023

3D Bioprinting Market Research Report: by Technology (Microextrusion Bioprinting, Inkjet 3D Bioprinting, Laser-assisted Bioprinting, Magnetic 3D Bioprinting), by Material (Living Cells, Hydrogels, Extracellular Matrices), by Application (Research Applications, Clinical Applications), by End-user (Pharmaceutical & Biotechnology Companies, Research Organizations & Academic Institutes), and Region - Global Forecast till 2023

Global 3d Bioprinting Market is expected to reach a projected valuation of USD 1,923.02 million by 2023. The 3D Bioprinting market is calculated to register a striking CAGR of 24.59% during the forecast period. It is reported that the growing demand for organ transplantation is expected to push the growth of the 3D Bioprinting Market. Also, rising occurrences of organ failure owing to accidents, diseases, and old age have created a massive gap for the functioning of organs. The emergence of 3D bioprinting can fill-in the gap by producing them on a massive scale.
Furthermore, the cost-effective nature of the technology is expected to drive the market demand as well. 

Opportunities related to the manufacturing of pills for the pharmaceutical sector and for producing prosthetics and implants is anticipated to augment the market too. The rising investment for R&D activities is expected to broaden the potential of the technology and subsequently the market growth.

3d Bioprinting Market Segmentation
The Global 3d bioprinting market segmentation is based
  • material
  • application
  • end-user
  • technology
By technologies, the 3D bioprinting market includes magnetic
  • 3D bioprinting
  • inkjet 3D bioprinting
  • laser-assisted bioprinting
  • microextrusion bioprinting
The microextrusion bioprinting is expected to grow significantly during the forecast period. Additionally, Inkjet 3D bioprinting segment is also anticipated to hold a significant share of the market due to its compatibility with living cells.
By material, the 3D bioprinting market includes
  • living cells
  • extracellular matrices
  • hydrogels
  • others
The living cells segment hold a major portion of the share due to its manufacturing using in-air microfluidics. Hydrogels segment is too expected to garner high demand in the forthcoming years.
By application, the 3D bioprinting Industry divides into
  • clinical
  • research applications
It is expected for the clinical applications segment to pose a higher market share due to the demand of organ transplantation.
By end-user, the market segments into pharmaceutical & biotechnology companies and research organization & academic institutes. Both the segments are expected to grow in numbers in the forthcoming years.

3d Bioprinting Market Competitive Landscape
The Global 3d Bioprinting Market holds several key and prominent players, including FUJIFILM Wako Automation Corporation (U.S.), Regenhu Ltd. (Switzerland), Cyfuse Biomedical K.K. (Japan), Organovo Holdings Inc. (U.S.), Stratasys Ltd. (U.S.), EnvisionTEC GmbH (Germany), Cellink AB (Sweden), Allevi (U.S.), Regenovo Biotechnology Co. Ltd. (China), Aspect Biosystems Ltd. (Canada), Nano3D Biosciences Inc. (U.S.), and Poietis (France).

March 25th, 2019, CD3D, a Poland-based 3D printer company, announced the launch of the largest open 3D bioprinting cluster in Europe. Located in Lodz, Poland, the cluster consists of 21 SKAFFOSYS bioprinter units. The units will be leveraged upon to pursue R&D activities in the biomedical arena.

March 22nd, 2019, Allevi, a Philly-based 3D bioprinting company, introduced the innovative Skin Bioink Kit. The kit needs to be used in conjunction with its 3D bioprinters to create skin patches. The launch of the product is aimed at allowing tissue engineers to design multi-layered skin patches that are similar to natural human skin.

3d Bioprinting Market Regional Analysis
The geographical segmentation of the global 3D bioprinting market is focused upon regions like Asia Pacific, the Americas, Europe, and the Middle East & Africa.

As per the last conducted study in 2017, the Americas held the highest share of the market due to considerable increase in research & development activities, existence of a large patient pool, development of healthcare infrastructure, and increasing budget expenditure of healthcare in countries like the US and Canada.
The European region held the second position in the global standings in terms of market share. This is primarily due to the surging investment in 3D printing and a high demand in countries like the UK, France, and Germany. Additionally, increasing application of the 3D bioprinting technology in the cosmetic sector alongside the band on animal testing are key factors that can further push the market growth in this region.

The Asia Pacific region is expected to garner the highest growth percentage over the forecast period due to the developing healthcare industry in China and other emerging economies. Also, collaboration among leading companies to set-up units, and increasing funding for research and development activities are expected to push the growth of the region further.

Table Of Contents:
  • Report Prologue
  • Market Introduction
  • Research Methodology
  • Market Dynamics
  • Market Factor Analysis
  • Global Cardiac 3D Bioprinting Market By Technology
  • Global Cardiac 3D Bioprinting Market By Material
  • Global Cardiac 3D Bioprinting Market By Region
  • Global Cardiac 3D Bioprinting Market By End User
  • Competitive Landscape
  • Company Profiles
  • Appendix
  • List of Tables
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Wednesday 22 January 2020

Intraoperative Neurophysiological Monitoring Market Demand, Sales, Profit | Forcast To 2027

Intraoperative Neurophysiological Monitoring Market Trends, Size and Application, By Type (EEG, EMG and Evoked Potential (EP)), Method (Invasive, Non-Invasive and Minimally Invasive), Source (In-house, Outsource and Tele-Health), Procedure (Spinal, Neurovascular, Orthopedic, Otolaryngology Surgery, Urology and others) and Region (North America, Europe, Asia-Pacific and the Middle East & Africa) - Forecast to 2027

Intraoperative Neurophysiological Monitoring Market Overview
The intraoperative neurophysiological monitoring market is forecasted to earn revenues worth USD 1.1 billion while expanding at a CAGR of 8.9 % in the coming years. The precision in surgical procedures is developing due to better knowledge transfer and experience to handle a wide range of cases. Reports that assess the healthcare industry have been presented by Market Research Future, which creates reports on numerous industry verticals that examine the market progress and forecasts.

The progress in the establishment of cutting-edge facilities has created a favorable impetus for the growth of the intraoperative neurophysiological monitoring market. The factor of cost-effectiveness is also expected to considerably impact the advancement of the market in the impending period. Moreover, growing understanding related to the treatment of neurological ailments and better tools to operate in case of surgical intervention is expected to accelerate the growth of the intraoperative neurophysiological monitoring market in the forthcoming period.

Intraoperative Neurophysiological Monitoring Market Competitive Analysis
The surge in the market is credited to the presence of favorable market forces are expected to complement the development of the market. The positive reinforcement of the forces of demand and supply is expected to lift the market growth in the coming years. The synergies achieved in the manufacturing of the goods in the market are enhanced, leading to better growth prospects. The availability of productive resources is expected to further the progress of the market in the forecast period. The increased transaction level in the market is expected to spur an accelerated level of growth in the market. The conception of prodigious competitive advantages is likely to support the progress of the market. A considerable ascension in the number of promoters in the market is estimated to form a beneficial outlook for market growth in the projected period. The relaxation of the barriers to the entry of new players in the market is expected to encourage the expansion of the market in the impending years.

The chief competitors in the intraoperative neurophysiological monitoring market are Accurate Monitoring LLC, Argos NeuroMonitoring LP, Computational Diagnostics Inc., Emotiv, Inomed Medizintechnik GmbH, Medsurant Holdings LLC, Cadwell Laboratories Inc., Natus Medical Incorporated, NuVasive, Neuro Alert, NuVasive, Neuromonitoring Technologies Inc., NeuroSentinel LLC, Procirca, Propep Surgical, 
SpecialtyCare and Sentient Medical Systems.

Intraoperative Neurophysiological Monitoring Market Segmental Analysis
The segmentation of the intraoperative neurophysiological monitoring market is carried out based on type, procedure, methods, source, and region. Based on type, the intraoperative neurophysiological monitoring market is segmented into electromyography, electroencephalography, and evoked potentials. Based on procedure, the intraoperative neurophysiological monitoring market is segmented into otolaryngology surgery, spinal, neurovascular, orthopedic, and urology. The segmentation of the market based on the methods consists of non-invasive, invasive, and minimally invasive. Based on source, the intraoperative neurophysiological monitoring market comprises of outsourced, in-house, and telehealth. By region, the intraoperative neurophysiological monitoring market consists of Europe, Asia Pacific, North America, Middle East, and Africa.

Intraoperative Neurophysiological Monitoring Market Regional Analysis     
The assessment of the regions in the intraoperative neurophysiological monitoring market comprises of regions such as Europe, Asia Pacific, North America, Middle East, and Africa. The North American region is projected to head the IONM market with a noteworthy market share.  The factors such as the increasing demand for the spinal and cranial procedures controlled by the rising number of patients is supporting the market growth of this region. The IONM market in the European region is responsible for the second largest stake in the market globally.
The region is projected to reveal strong growth through the forecast period.  The existence of the well-proliferated healthcare sector is leading to a growing number of advanced treatment facilities motivated by the increasing demand for better healthcare infrastructure and increasing healthcare expenditures. The Asia Pacific market for IONM appears as a lucrative market with the intensifying number of patients enduring spinal ailments and the ever-increasing population that is disposed towards a sedentary lifestyle. The growing funding from the government and private organizations are encouraging market growth by increasing the R&D activities in the region.

Brows More Healthcare Related Research Reports at:

About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. 
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

at No comments:

Stroke Post Processing Software Market Overview, Opportunities and Applications | Forcast To 2024

Stroke Post Processing Software Market Growth, Insights and Insights by Installation (Desktops, Mobile Phones and Tablets), by Modality (CT Scan and MRI), by Type (Ischemic Stroke, Hemorrhagic Stroke and others), by End User (Hospitals & Clinics, Specialty Centers and others) and by Region (Americas, Europe, Asia Pacific and Middle East & Africa) - Forecast till 2024

Stroke Post Processing Software Market Overview
The Global Stroke Post Processing Software Market is expected to register a CAGR of 6.48% during the forecast period, with a market value of USD 898.87 Million in 2018. A stroke can be defined as the lack of blood flow to brain tissues and can occur in any vascular structure within the brain.

This research report provides insights, on various levels of analysis, such as industry analysis, market share analysis, leading market players, and their profiles. This report also helps in studying the target segments by providing views on emerging and high-growth segments and market conclusion. Together the market data comprises and discusses basic assessments on the competitive scenarios and strategies of the global stroke post processing software market, including the high-growth regions and their political, economic, and technological environments. Furthermore, the project report also provides views over historical market values as well as pricing and cost analysis of the same.
The collaborations between start-up companies & big market players in the industry, increasing burden of ischemic strokes, and growth in the geriatric population are likely to contribute to the growth of the market during the assessment period. For instance, in January 2019, iSchemaView and NeuroLogica, a subsidiary of Samsung Electronics Co., Ltd and leader in medical imaging technology, collaborated to integrate iSchemaView’s RAPID cerebrovascular imaging platform with NeuroLogica’s portable CereTom CT scanners for use in MSUs and ICUs across the globe. However, stringent regulatory policies is likely to restrain the market growth during the forecast period.

Stroke Post Processing Software Market Segmentation
The global stroke post processing software market, by installation, has been segmented into the desktop, mobile phones, and tablets. By modality, the market has been segregated into CT Scan and MRI. Based on type, the market has been divided into the ischemic stroke, hemorrhagic stroke, and others. Based on the end user, the global stroke post processing software market has been classified as hospitals & clinics, specialty centers, and others. The hospitals and clinics segment accounted for a value of USD 479.89 million in 2018.

Stroke Post Processing Software Market Players
Market Research Future (MRFR) recognizes the following companies as key players in the global stroke post processing software market that include Brainomix (UK), Viz.ai, Inc. (US), iSchemaView, Inc. (US), General Electric Company (US), Koninklijke Philips NV (Netherlands), and Siemens (Germany).

Stroke Post Processing Software Market Regional Analysis
Geographically, the global stroke post processing software market has been categorized as Europe, the Americas, Asia-Pacific, and the Middle East & Africa. Europe is expected to hold the largest share of the global stroke post processing software market. This is due to the presence of a well-developed healthcare infrastructure. Moreover, European companies offering stroke post processing software are getting involved in collaborations, mergers, and product launches to gain substantial market share, which in turn is positively affecting market growth.
Americas showed a considerable amount of growth in the market due to the presence of an established healthcare system and two major stroke post processing software companies in the US, namely Viz.ai, Inc. and iSchemaView, Inc. Asia-Pacific is estimated to be the fastest-growing region in the global market due to the presence of some rapidly developing economies. Also, the availability of scientific expertise in Asia-Pacific is likely to contribute to market growth. The large patient pool for heart diseases in Asia-Pacific creates additional opportunities for market growth. Japan held a share of 28.5% in the Asia-Pacific stroke post processing software market in 2018. Also, the market in the Middle East & Africa is expected to demonstrate slow growth.

Key Findings of the Study
The Global Stroke Post Processing Software Market is projected to reach USD 1,294.24 million by 2024 at a CAGR of 6.48% during the review period from 2019 to 2024.

Europe accounted for the largest share of the global market due to the focus of major players in the region.
The hospitals & clinics segment accounted for the largest end user segment, with a revenue of USD 89 million in 2018.

Brows More Healthcare Related Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Arterial Blood Collection Devices Market Dynamics, Trends and SWOT Analysis | Forcast To 2023

Arterial Blood Collection Market Share, Growth And Trends Analysis By Type (Blood Collection Tubes, Lancet, Needles, Vacuum Blood Collection System, Microfluidic System And Others), Application (Arterial Blood Gas Sampling And Intraoperative Blood Salvage), End User (Hospitals & Clinics, Blood Banks, Laboratories And Others) And Region (Americas, Europe, Asia-Pacific And Middle East & Africa) - Global Forecast Till 2023

Global Arterial Blood Collection Devices Market Overview
The Global Arterial Blood Collection Devices Market Size is expected to grow at a CAGR of 9.1% during forecast period 2017-2023. Blood collection involves withdrawal of blood from a vein or artery to diagnose disease or for any surgical procedure. The process of making incision into the vein is known as phlebotomy. This procedure is also known as venipuncture. Phlebotomist is a person performing venipuncture. He may be a doctor, nurses, medical laboratory professional or other healthcare provider.

The global arterial blood collection devices market is expected to grow at a rapid pace. The factors influencing the growth of the market include rising number of surgical procedures, demand of blood for emergency care, high incidence of chronic diseases contribute to the growth of this market. Restrains inhibiting the growth of this market are risk of transfusion transmissible infection and growing inclination towards robotic surgery. However, technological advancements represent significant growth opportunities for the growth of the arterial blood collection devices market during the forecast period

Arterial Blood Collection Devices Market Competitive Analysis
Becton, Dickinson and Company (U.S), Bio-Rad Laboratories, Inc. (U.S), NIPRO Medical Corporation (Japan), Qiagen (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Terumo Medical Corporation (U.S), Thermo Fisher Scientific, Inc. (U.S) are some of the prominent players at the forefront of competition in the Global Arterial Blood Collection Devices Industry and are profiled in MRFR Analysis. 

Globally, many players are operating in arterial blood collection devices market. Leading market players have their headquarters in America & Germany as well as they also enjoy global presence. Major market in arterial blood collection devices market are Becton, Dickson and Company, Bio-Rad Laboratories, Inc., NIPRO Medical Corporation, QIAGEN, F. Hoffmann-La Roche Ltd, Terumo Corporation, and Thermo Fisher Scientific, Inc. which account for more than 50% of shares in this market. These players contribute to growth of this market by manufacturing blood collection devices to meet the demand of the market.

Global Arterial Blood Collection Devices Market Regional Analysis
Global arterial blood collection devices market is segmented based on geographies or regions which mainly includes Americas, Europe, Asia Pacific, and Middle East & Africa.

Americas is the largest market for arterial blood collection devices. It comprises of two regions namely North America and South America. Important factors driving the growth of this market are demand of safe & reliable blood collection devices, concentration of major market players manufacturing blood collection devices, and extensive need of diagnostic services. Risk of blood transfusion transmissible infection may act as an obstacle for the growth of this market.

In 2016, North America accounted for the largest market share owing to an increase in demand of diagnostic procedures, awareness regarding use of sterile devices for blood collection, and technological advancement in the field of clinical diagnostics. Furthermore, increasing number of surgical procedures and high prevalence of lifestyle disease are also contributing to the growth of this market.

According to the America's Blood Centers, one in every seven people entering the hospital needs blood. It also stated that in the U.S, more than 15 million pints of blood is transfused every year and more the 40 thousand pints of blood is transfused daily in the U.S and Canada.

Rapid population growth and need of diagnostic devices & blood collection devices are important drivers of this market in South America.

Europe holds the second largest share of the global arterial blood collection devices market. Asia Pacific is the fastest growing arterial blood collection devices market across the globe. Demand of arterial blood collection devices mainly syringes, and needles is increasing with an increase in incidence of lifestyle diseases such as diabetes and chronic heart diseases, aging population, as well as growing number of surgical procedures performed in hospitals. Increase in number of blood donations centres has been found in Asia Pacific due to rising awareness regarding the need of blood & blood products for live saving treatment & emergency care.

However, the Middle East & Africa holds the least share of the global market due to limited availability of medical facilities.

Brows More Healthcare Related Research Reports at:

About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact
Market Research Future
Office No. 528,
Amanora Chambers Magarpatta Road,
Hadapsar,
Pune - 411028
Maharashtra,
India  +1 646 845 9312

at No comments:

Ticagrelor Market Profile, Key Players and Segmentation | Forcast To 2027

Ticagrelor Market: Information by Dosage (Mg) (90 MG and 60 MG), Route of Administration (Oral and Nasogastric Tube), Application (Acute Coronary Syndrome and Heart Surgeries (Angioplasty, Stent Placement and Coronary Artery Bypass Graft)) End User (Hospitals and Clinics and Ambulatory Centers) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) – Global Forecast till 2027

According to a leading research firm - Market Research Future (MRFR), the global Ticagrelor Market Size is poised to register a valuation of USD 2554.39 MN by 2027. In its newly published study report, MRFR also asserts that the market would post a CAGR of 9% throughout the review period (2017 – 2027). Ticagrelor drugs are primarily used in the treatment of cardiovascular disorders and other heart conditions, including diseased vessels, structural problems, and blood clots. In acute coronary syndrome, the combination of ticagrelor and aspirin is reported to have reduced the rate of vascular deaths and myocardial infarctions. As a result, ticagrelor drugs garner a vast market prominence and its market witness’s pervasive growth. Increasing occurrences of cardiovascular disorders is a dominant driving force behind the growth of the market. Besides, the rise in the geriatric population has a direct impact on the growth of the market. 

Additionally, increasing occurrences of obesity are encouraging the market demand, fuelling the cardiovascular patient pool. Also, growing numbers of drug manufacturers are driving the growth of the market, bringing novel medications in the market. Substantial investments transpired into R&D activities driven by improving economic conditions provide impetus to the growth of the market. 

Conversely, factors impeding the growth of the market, include patent expiries and side effects of Ticagrelor such as bleeding that can sometimes go worst, leading to death. Nevertheless, factors such as substantial technological strides that increase the efficacies of Ticagrelors would support market growth, increasing market demand. 

Ticagrelor Market Regional Analysis
North America leads the global Ticagrelor market with the largest market share. Heading with the rising geriatric population that is highly prone to degenerative diseases and prevalent chronic diseases, the region is estimated to retain its dominance throughout the forecast period. Additionally, the presence of a well-developed healthcare sector, alongside, the high per capita healthcare expenditures and well-spread awareness drive the regional market growth. 
Growing markets in the US and Canada backed by the presence of prominent market players, positively impact the growth of the Ticagrelor market in the region. Furthermore, increasing diagnosis and therapeutics would support the market to create a significant revenue pocket during the assessment period (2017-2027). 

The Ticagrelor market in the European region accounts for the second-largest market, globally. The rising patient population of strokes & cardiovascular disorders and the introduction of advanced & integrated treatment options are expected to boost the regional market growth. 

Moreover, factors such as favorable government support for researches on antiplatelets, availability of advanced treatment facilities, and increasing healthcare expenditure, foster the growth of the market in the region. The UK, backed by its sizeable Ticagrelor market and Germany with its vast medical technology and pharmaceutical industry, contribute to the growth of the regional market, significantly.  

The Asia Pacific Ticagrelor market is rapidly emerging as a promising market globally. Factors like increasing per capita disposable income and government initiatives to enhance the quality of healthcare drive the regional market growth. Moreover, the burgeoning pharmaceutical industry in this region is predominantly influencing the growth of the APAC Ticagrelor market.

Additionally, spreading awareness towards the disorder and the availability of novel treatment procedure to manage the condition influence the growth of the regional market, positively. Furthermore, the rising prevalence of cardiovascular diseases led by the changing lifestyles alongside, the continually rising healthcare expenditures and favorable government policies substantiate the market growth in the APAC region.

Ticagrelor Market Segmentation
The report is segmented into five market dynamics to widen the scope of understanding,
By Dosage: 90 Mg and 60 Mg.
By Route of Administration: Oral and Nasogastric Tube.
By Route of Application: Acute Coronary Syndrome, Heart Surgeries, Angioplasty, Stent Placement, and Coronary Artery Bypass Graft, among others.
By End-user: Hospitals & Clinics and Ambulatory Centers, among others.
By Regions: Europe, North America, Asia Pacific, and the Rest-of-the-World.

Ticagrelor Market Competitive Analysis
Fiercely competitive, the Ticagrelor market appears to be fragmented due to the presence of many players. Large and small players alongside, the new entrants form a competitive landscape. They try to gain a substantial market share through strategic initiatives such as mergers & acquisitions, expansion, collaboration, and product/ technology launch.

 Major Players: 
Players leading the global Ticagrelor Industry include Eli Lilly, AstraZeneca, Boehringer, Pfizer, Ingelheim, Amgen, Roche, Merck, GSK, Ingelheim Pfizer, Alexion, Boehringer, and Amgen, among others. 

Brows More Healthcare Related Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

at No comments:

Mastitis Market Insights, Growth and Applications | Forcast To 2023

Mastitis Market Size, Growth and Analysis by Type (Bovine {Contagious Mastitis, Environmental Mastitis and Opportunist Mastitis} and Human {Non-Infectious Mastitis and Infectious Mastitis}), by Treatment (Bovine {Antibiotics and Vaccines} and Human {Pain Relievers and Antibiotics}), by End User (Veterinary Centers and Hospital & Clinics) and by Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023

Market Overview:
The Global Mastitis Market Size was valued USD 7,898.05 Million and projected to reach USD 18,338 Million at a CAGR of 15.07% during the forecast period (2017-2023) says Market Research Future (MRFR). The North America mastitis market is expected to reach USD 7,054.58 Million followed by European mastitis market to reach USD 5,275.18 million and APAC mastitis market will reach the valuation of USD 5,000.41 million by 2023.
Mastitis refers to a kind of infection occurring in the tissues of mammary glands in the breast. The mastitis usually affects women who are breastfeeding as a result of a blocked duct. In cows, mastitis occurs as a result of chemical, mechanical, or thermal injury to the cow’s udder.

Rapid changes in lifestyle, eating habits, and changes in the social system over the last few years have been accelerating the market growth. According to the World Cancer Research Fund, breast cancer is the most common cancer in women worldwide and the second most common cancer. The World Cancer Research Fund has also reported over 2 million new cases of breast cancer in 2018.

However, lack of awareness towards the mastitis conditions, low awareness levels regarding bovine health, and the lack of awareness of losses caused by bovine mastitis are some of the factors hampering the market growth. Consequences in incorrect diagnosis due to similarities in the symptoms of breast cancer and mastitis can hamper the market growth.

Affected bovine and human population are driving the growth of the global mastitis market. With the various technological advancements in recent years, the global mastitis market has been witnessing many innovations in treatment methods and drugs to treat the infection.

Furthermore, factors such as the growing prevalence of breast cancer is impacting the market growth positively.  Women affected with breast cancer are at high-risk of contracting mastitis during the breastfeeding period. Hence, the rise in the breast cancer cases across the globe accounts for the key risk factor increasing the incidents of the mastitis.

Mastitis Market Competitive Dashboard:
Prominent players operating in the mastitis market include Bayer AG (Germany), Pfizer Inc. (U.S.), BioNumerik Pharmaceuticals Inc. (U.S.), Zoetis Inc. (U.S.), Sanofi S.A. (France), Merck Co & Inc. (U.S.), Oncothyreon Inc. (U.S.), Oncogenex (U.S.), Apthera Inc. (U.K.), Astellas Pharma Inc. (Japan), Novartis AG (Switzerland), Boehringer Ingelheim GmbH (Germany), F. Hoffmann-La Roche Ltd. (Switzerland).
Strategic initiatives employed often involve mergers, acquisitions, product launches, and others. These tactical moves ensure individual growth of companies alongside the market’s expansion.

Mastitis Market Segmentation:
The global mastitis market can be segmented by type, treatment, end-user, and region.
By type, the global mastitis market is segmented into human mastitis and bovine mastitis. The segment bovine mastitis accounted for the major share in the global mastitis market in 2017. Whereas the subsegment contagious mastitis had valued at USD 3,843.23 MN in 2017 and is expected to exhibit a CAGR of 16.91 % during the forecast period (2017-2023). Environmental mastitis accounted for a 38 % of the share of bovine mastitis, in 2017.
By treatment, the mastitis market is segmented into antibiotics, pain relievers, surgery, vaccines, and others. Antibiotics by bovine treatment accounted for the valuation of USD 6,448.56 million in 2017. The antibiotics subsegment is further expected to register a CAGR of 16.56% throughout the forecast period.

Based on end-user, the mastitis market is segmented into hospitals, clinics, veterinary centers, and others. In 2018, the hospitals and clinics segment is expected to account for the largest share of the global mastitis market. Veterinary centers accounted for the largest share of the market in 2017.

The subsegment Veterinary centers by the end-user accounted for the valuation of approximately USD 6,326.34 million in 2017 and is projected to register a CAGR of 16.87% over the forecast period.

Mastitis Market Regional Analysis:
The Americas region dominates the global mastitis market share mainly due to the higher health care expenditures and the increasing prevalence of mastitis among the bovine population. The US backed by the growing prevalence of human mastitis, and bovine’s mastitis accounts for the major growth supporter to the regional market.
Europe mastitis market stands the second position, globally mainly due to the high prevalence of breast cancer. Moreover, factors such as the accessibility to advanced treatment facilities, rising government initiatives to promote healthy breastfeeding, and growing healthcare expenditures are fostering the growth of the regional market.
The mastitis market in the Asia Pacific region is expected to emerge as a promising market, growing rapidly due to the government initiatives of healthcare reforms. Increasing demand for advanced treatment therapies mainly in emerging economies such as China and India are leading the growth in the mastitis market in the region.

Brows More Healthcare Related Research Reports at:

About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312


at No comments:

Tuesday 14 January 2020

Leukapheresis products Market Growth, Sales, Cost and Profit | Forecast to 2023

Global Leukapheresis Products By Type (Leukapheresis Devices, Leukapheresis Disposables), by Application (Research Applications, Therapeutic Applications), By End User (Blood Component Provider and Blood Center, Other) -Forecast Till 2023

Market Highlights:
Leukapheresis is a laboratory procedure in which white blood cells (WBCs) are separated from a sample of blood. Leukapheresis is majorly carried out for chronic lymphocytic leukemia. It is anticipated that the leukapheresis products market held a market value of USD 19.2 million in 2017 and is projected to grow at a CAGR of 7.7% over the forecast period.

 The factors such as increasing number of blood donations, rising prevalence of leukemia, and demand for leukapheresis products in clinical research are anticipated to propel the growth of the market over the forecast period. According to the National Institutes of Health (NIH) estimates, the number of new cases of leukemia has increased on an average rate of 0.3% each year over the period from 2006-2015. It also stated that the number of new cases may reach 60,300 in the year 2018. Despite the drivers, the high cost of therapeutic leukapheresis, dearth of skilled professionals, and stringent donor recruitment criteria may hamper the market growth over the assessment period.

Currently, many companies are operating in the global leukapheresis products market. The prominent players in the market are engaged in strategic collaborations, acquisitions, regional expansion, and new product launches to strengthen their market position. For instance, in February 2018, Terumo BCT entered into collaboration with Stafa Cellular Therapy. With this collaboration, Terumo BCT will act as a distributor for Stafa Cellular Therapy and will expand its access to StafaCT software to healthcare organizations.

Regional Analysis:
Geographically, the Americas is anticipated to dominate the global leukapheresis products market owing to the rising number of blood donations, and growing incidence and prevalence of leukemia. Europe is anticipated to hold the second largest position in the global leukapheresis products market. The market growth in this region is mainly due to the rising prevalence of leukemia and presence of well-developed healthcare sector in the region. Asia-Pacific region is expected to be fastest growing region due to the increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the increasing presence of major pharma and biotech companies. The Middle East & Africa has the least share of the global leukapheresis products market owing the poor healthcare infrastructure especially in the Africa region.

Segmentation:
The global leukapheresis products market has been segmented into type, application, and end user. On the basis of type, the market has been segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment has been segmented into apheresis devices, leukapheresis column & cell separators, and leukoreduction filters.

The market, by application, has been segmented into research applications and therapeutic applications.
On the basis of end user, the market has been segmented into blood component providers and blood centers, hospitals and transfusion centers, and others.

Key Players:
Some of the prominent players in the global leukapheresis products market are Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, and StemExpress

Brows More Healthcare Related Research Reports at:

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com .

at No comments:

Percutaneous Coronary Intervention Market Insights, Share, Emerging Trends | Forecast to 2023

Global Percutaneous Coronary Intervention Market by Product Type (Coronary Stents, PTCA Catheters, Coronary Guidewire and Accessories), by End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Research and Academic Institutes and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2023

Overview:Percutaneous Coronary Intervention Market is a non-invasive procedure used to treat narrowing arteries of the heart in coronary artery diseases including angina, acute myocardial infarction, and multivessel coronary artery disease (CAD), among others.  PCI procedure involving cardiac catheterization help in providing relief in the symptoms of coronary heart diseases and reduce damages to the heart after or during a heart attack.

In recent years, the growing prevalence of chronic diseases related to heart, globally, the percutaneous coronary intervention market is growing at a rapid pace.  Moreover, the increasing adoption of PCI procedures performed on patients with coronary artery disease is escalating the market constantly.

Considering all these factors, the global percutaneous coronary intervention market is expected to reach over USD 15,205 million by 2023, growing at approximately 7.10% CAGR during the forecast period (2018-2023). The market stood at USD 10,160.9 million in 2017.

In addition to the growing prevalence of coronary heart diseases, the ever-increasing population worldwide and the increasing demand for the quality healthcare systems are factors expected to propel market volume till 2023.
Moreover, risk factors causing the heart-related diseases such as the increasing inclination towards the heady & sedentary lifestyle, and wrong eating habits, and changes in the social system over the last few years have been accelerating the market growth, increasing the incidents of the disease related to the heart.
However, the stringent government regulations for the approval of medical devices used in PCI alongside the lack of awareness towards the availability of percutaneous coronary intervention procedure may hinder the market growth over the forecast period. Also, the potential implications in diagnosis such as the infection caused during the procedure that can be challenging to diagnose and may have severe consequences are affecting the market growth.

Regional Analysis:The Global Percutaneous Coronary Intervention Market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. Among these, the Americas region dominates the market attributing to the increasing pool of awareness and the growing acceptability of percutaneous coronary intervention techniques.  

The region accounted for almost 39% of the market share in 2017, followed by Europe accounting for 31% of the market share. Whereas, the Asia Pacific region can grow at a rapid clip mainly due to the increasing prevalence of cardiovascular diseases.  The region had accounted for around 23% of the market share.

The Americas region dominates the global percutaneous coronary intervention market mainly due to the higher health care expenditures and the increasing prevalence of diseases such as cardiovascular and coronary artery disease. Factors such as well-spread awareness and the growing adoption of percutaneous coronary intervention techniques are driving the growth of the PCI market in the Americas.

In the US, percutaneous coronary intervention is one of the two most common procedures performed on patients with coronary artery disease. The US backed by the growing prevalence of cardiovascular angiography and interventions accounts for the major growth supporter to the regional market. The percutaneous coronary intervention market in the Americas is expected to reach USD 4,894.7 million by 2023.

The Europe Percutaneous Coronary Intervention Market is projected to register over 6% CAGR during the forecast period valued at approximately 4,600 Mn USD by 2023. The region assumed the second position in 2017 globally due to the rise in percutaneous coronary intervention centers in European countries. Furthermore, the increased number of hospitalizations for percutaneous coronary intervention procedures such as carotid artery angioplasty and cerebral angioplasty have been fostering the regional market.

The Percutaneous Coronary Intervention Market in the Asia Pacific region is expected to emerge as a promising market, growing rapidly due to the increasing prevalence of cardiovascular diseases, rapidly developing healthcare infrastructure, and improving economic conditions in the region. Simultaneously, the increasing number of research and development centers positively impacts the growth of this market.

Furthermore, owing to the factors such as the government initiatives of healthcare reforms and the increasing demand for advanced treatments in the region, the percutaneous coronary intervention market in the APAC will reach the valuation of USD 3,620.3 million by 2023.

Segmentation:The Global Percutaneous Coronary Intervention Market has been segmented on the basis of product type and end-user.

Various product types are segmented into coronary stents, percutaneous transluminal coronary angioplasty (PTCA) catheters, coronary guidewires, and accessories. Among these, the subsegment coronary Stent accounted for the largest share of 54% share in 2017. It was valued at USD 5452.5 million in the same year. It is further projected to grow at a CAGR of 7.81% during the forecast period.

By End-user, the market has been segmented into hospitals & specialty clinics, ambulatory surgical centers, research & academic institutes, and others. Out of these, the subsegment hospitals & specialty clinics accounted for 43% of the market share in 2017 and valued at USD 4,374.9 million. The subsegment is estimated to continue with its dominance registering a CAGR of 7.57% over the assessment period. The large share can be credited to the mushrooming of hospital chains amid increasing demands for quality patient care.

Competitive Dashboard:Prominent players operating in the percutaneous coronary intervention market include Boston Scientific Corporation (U.S.), Abbott (U.S.), ASAHI INTECC Company Limited (Japan), C. R. Bard, Inc (U.S.), Comed B.V. (The Netherlands), Meril Lifesciences Pvt Ltd. (India), BIOTRONIK (U.S.), Medtronic Plc (U.S.), B. Braun Melsungen AG (Germany), Biosensors International Group, Ltd. (Singapore), Terumo Corporation (Japan), Cordis (U.S.), Cook Medical (U.S.), and Merit Medical System (U.S.).

Strategic initiatives employed often involve mergers, acquisitions, product launches, and others. These tactical moves ensure individual company’s growth alongside the market’s expansion.

Brows More Healthcare Related Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

at No comments:

Pediatric neurology device Market Profile, Key Players, Dynamics | Forecast to 2023

The Global Pediatric Neurology Devices Market Size, Application and  Growth Analysis By Type (Neurostimulator, Others) Service & Treatment (Electroencephalogram, Others) Neurological Subspecialties (Stroke, Others) Age Group (Infants, Others) End User (Hospitals, Others) – Forecast till 2023

pediatric neurology device market will register approximately 6.3% CAGR between 2017 -2023, valuing exponentially by 2023. Common neurological disorders include stroke, Alzheimer's disease, ADHD, epilepsy, headache, Parkinson's disease, multiple sclerosis, sleep disorders, pain, brain, tremor, and spinal cord injuries, brain tumors, peripheral nervous disorders and amyotrophic lateral sclerosis occurring in children. Also, some not so serious issues such as seizures, delayed speech, poor muscle tone, or frequent headaches can be treated in pediatric neurology.

The pediatric neurology sector has been witnessing the emergence of many advent devices over the past few years that are offering effective outcomes. As a result, the global pediatric neurology device market is increasing pervasively. Factors such as the increasing prevalence of neurological disorders in children are fuelling the market growth to an extent. Also, the risk factors for these disorders are speeding up the market growth, creating the demand for the better diagnostic and treatment methods.

Additional factors substantiating the market growth include increasing governmental funding and programs especially in the developing regions to support the R&D activities undertaken for the invention of new devices.  Technological advancements that took place in the smart and connected devices and the proliferation of some ubiquitous technologies such as the Artificial Intelligence (AI) and Internet of Things (IoT) in the pediatric neurology devices foster the market growth.

Global Pediatric Neurology Device Market- Regional Analysis
Globally, North America is dominating the global pediatric neurology device market. Furthermore, factors such as extensive uptake of technologically advanced medical devices, increasing governmental support for R&D activities and high expenditures in the neurological care substantiate the market growth include.  With the growing prevalence of neurological disorders in children, the market is expected to evaluate phenomenally by 2023.

Europe region is another lucrative market for pediatric neurology device. Increasing focus on the development of advent diagnostic devices, rising government support for R&D activities is contributing to the market growth. Also, the increasing numbers of specialty services offered by various healthcare providers foster the growth of the market in the region.

The Asia Pacific is emerging as a promising market for pediatric neurology devices, growing rapidly.  Increasing incidents of neurological disorders are fuelling the market growth.  Moreover, factors such as the augmenting demand for quality devices in the healthcare and proliferating healthcare technology is projected to provide impetus to the market growth, leading to the increasing the uptake of advanced equipment.

Industry/Innovations/Related News:

October 4, 2018 - Dictum Health Inc., (US), innovators in telehealth's Virtual Exam Room (VER) technology, and eMD Telehealth Solutions, a telehealth company, announced their collaborative launch of Dictum Health's Care Central Telestroke Module in several regional hospitals to support local healthcare providers and patients with 24-hour access to neurologists including pediatric neurologists as well.

Brows More Healthcare Related Research Reports at:

About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

at No comments:
Subscribe to: Posts (Atom)

Ultra-low Temperature Freezers Market Profile, Trends and Applications By 2027

  According to the MRFR reports, the global   ultra-low temperature freezers market   is projected to acquire a market size of approximately...